← back to search

Pablo García Pavía

Sequoia (United States) · ES
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Cardiomyopathy and Myosin Studies, Amyloidosis: Diagnosis, Treatment, Outcomes, Cardiovascular Function and Risk Factors, and Infective Endocarditis Diagnosis and Management.
h-index
18
citations
2,542
works
107
NIH funding
primary concept
Medicine
email

Recent publications

Disease Prognosis and Progression in Transthyretin Amyloidosis
JACC CardioOncology 2026cited by 0position: middledoi
Aficamten and Cardiopulmonary Exercise Test Performance
JAMA Cardiology 2024cited by 23position: middledoi
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
Orphanet Journal of Rare Diseases 2022cited by 88position: middledoi
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet 2020cited by 1,173position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026)Ronald Witteles · Palo Alto University1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026) · 1 papers (2026–2026)Joban Vaishnav · University of Baltimore1 papers (2026–2026)Rajshekhar Chakraborty · Columbia University1 papers (2026–2026)Jan M. Griffin · Medical University of South Carolina1 papers (2026–2026)Chafic Karam · California University of Pennsylvania1 papers (2026–2026) · 1 papers (2026–2026)Brian C. Boursiquot · Columbia University1 papers (2026–2026)